Libre Assist is a breakthrough generative AI feature integrated directly into Abbott’s FreeStyle Libre mobile platform, launched in January 2026 at CES. Designed specifically for individuals living with diabetes, it moves beyond traditional food logging by providing predictive insights rather than just reflective data. By leveraging generative AI, the tool allows users to snap a photo of a meal or input food data to receive an instant prediction of its potential impact on their glucose levels before they take their first bite.

The feature is lauded for its ability to offer actionable, personalized guidance—such as suggesting ingredient swaps or portion adjustments—to mitigate predicted glucose spikes. Once the meal is consumed, the system uses data from the FreeStyle Libre 3 Plus or Libre 2 Plus sensors to confirm the actual outcome, creating a continuous learning loop for the user. While it is a revolutionary aid for “in-the-moment” decisions, it is strictly a supportive tool and is not intended for making direct medical treatment decisions. For the over 7 million people using Libre technology, Libre Assist represents a major leap toward intelligent, data-driven daily health management.